Aquestive Therapeutics Inc. (NASDAQ: AQST) reported Q2 EPS of ($0.14), $0.03 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $10 million versus the consensus estimate of $11.32 million.

For earnings history and earnings-related data on Aquestive Therapeutics Inc. (AQST) click here.